An innovation
Advanced wound care for animals
What is Pathelen® Vulnerex?
Pathelen Vulnerex is an advanced wound care product specifically designed to eliminate the biofilm that forms in wounds and is a major obstacle to effective healing. Biofilms are persistent in chronic wounds and hinder the natural healing process, usually leading to infection.
Pathelen Vulnerex is designed to prevent the formation of these biofilms in open wounds and to effectively eliminate existing biofilms in chronic wounds. This enables the formation of granulation tissue, which is an essential component of wound healing, within a very short time.
A unique feature of Pathelen Vulnerex is its non-pharmacological mode of action. This means that it works without interfering with physiological or biochemical processes in the body, thus eliminating any risk of systemic side effects. It is a safe, quick and easy solution for wound care in pets and horses.
Pathelen Vulnerex is extremely easy to use. The ease of use is part of our commitment to providing you and your animal companions with a hassle-free path to recovery. Plus, the fast-acting formula means you'll notice an improvement in your animal or horse's condition in no time.
Invest in the health of your pets and horses today with Pathelen Vulnerex. It is not just a treatment, but a promise of care and rapid healing. Pathelen Vulnerex - the safe and fast solution for wound healing.
Benefits of wound treatment with Pathelen® Vulnerex
Easy to use
Pathelen® Vulnerex is easy to apply to any type of wound. Shake the bottle for about 10 seconds until the powder turns into a liquid-like state and spread it over the wound. Dress the wound with a wound dressing of your choice.
Fast
effectiveness
After applying Pathelen® Vulnerex to the wound, the wound status should be checked every 48 hours.
Granulation tissue should usually form within 5-10 days.
No
side effect
Pathelen® Vulnerex works purely physically, which means there is no pharmacological mode of action.
For this reason, no side effects were observed during testing of Pathelen® Vulnerex.